5NUM
Engineered beta-lactoglobulin: variant F105L-L39A in complex with chlorpromazine (LG-LA-CLP)
5NUM の概要
| エントリーDOI | 10.2210/pdb5num/pdb |
| 分子名称 | Beta-lactoglobulin, 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine, PHOSPHATE ION, ... (4 entities in total) |
| 機能のキーワード | beta-lactoglobulin, lipocalin, complex, mutant, transport protein |
| 由来する生物種 | Bos taurus (Bovine) |
| 細胞内の位置 | Secreted: P02754 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 18570.75 |
| 構造登録者 | Loch, J.I.,Bonarek, P.,Tworzydlo, M.,Lazinska, I.,Szydlowska, J.,Lewinski, K. (登録日: 2017-04-30, 公開日: 2018-04-04, 最終更新日: 2024-11-06) |
| 主引用文献 | Loch, J.I.,Bonarek, P.,Tworzydlo, M.,Lazinska, I.,Szydlowska, J.,Lipowska, J.,Rzesikowska, K.,Lewinski, K. The engineered beta-lactoglobulin with complementarity to the chlorpromazine chiral conformers. Int. J. Biol. Macromol., 114:85-96, 2018 Cited by PubMed Abstract: Chlorpromazine (CPZ) is a phenothiazine acting as dopamine antagonist. Aside from application in schizophrenia therapy, chlorpromazine is found to be a putative inhibitor of proteins involved in cancers, heritable autism disorder and prion diseases. Four new β-lactoglobulin variants with double or triple substitutions: I56F/L39A, F105L/L39A, I56F/L39A/M107F or F105L/L39A/M107F changing the shape of the binding pocket were produced and their chlorpromazine binding properties have been investigated by X-ray crystallography, circular dichroism, isothermal titration calorimetry and thermophoresis. The CD spectra and crystal structures revealed that mutations do not affect the protein overall structure but in comparison to WT protein, variants possessing I56F substitution had lower stability while mutation F105L increased melting temperature of the protein. The new variants showed affinity to chlorpromazine in the range 4.2-15.4 × 10 M. The CD spectra and crystal structures revealed complementarity of the binding pocket shape, to only one chlorpromazine chiral conformer. The (aR)-CPZ was bonded to variants containing I56F substitution while variants with F105L substitution preferred (aS)-CPZ. PubMed: 29555509DOI: 10.1016/j.ijbiomac.2018.03.074 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.3 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






